Apolipoprotein CIII as a therapeutic target in obesity-associated metabolic dysfunction
Adv Biol Regul. 2026 Oct 8:101183. doi: 10.1016/j.jbior.2026.101183. Online ahead of print.ABSTRACTApolipoprotein CIII (apoCIII) is a major regulator of lipid metabolism and increased levels are related to higher risk of cardiovascular disease. Increasing evidence, however, suggests that apoCIII may

